Our Portfolio ASX-100 neutrophil targeting platform to treat significant unmet medical needsPI: Dr. Lola Eniola-Adefeso, University of MichiganVisit site Targeted therapeutics platform for Infectious diseasesPI: Dr. Philip Low, Purdue University Single molecule protein sequencingPI: Dr. Edward Marcotte, University of Texas at AustinVisit site Hyper-targeted small molecules for reprogramming immune cells to treat diseasePI: Dr. Philip Low, Purdue UniversityVisit site Fracture targeting therapeutic for bone healingPI: Dr. Philip Low, Purdue UniversityVisit site Immunoproteasome modulating therapeutics to transform treatment of autoimmune and inflammatory diseases.PI: Gang Lin, Ph.D. and Carl Nathan, M.D. of Weill Cornell Medicine Personalized AI for Precision Psychiatry.PI: Dr. Philip Corlett, Yale UniversityVisit site
